<DOC>
	<DOCNO>NCT00004090</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase I trial study effectiveness gemcitabine cisplatin treat patient metastatic recurrent solid tumor .</brief_summary>
	<brief_title>Gemcitabine Cisplatin Treating Patients With Metastatic Recurrent Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine toxicity maximum tolerate dose gemcitabine cisplatin patient metastatic recurrent nonhematologic malignancy . OUTLINE : This dose escalation study gemcitabine . Patients receive gemcitabine IV day 1 8 , follow immediately cisplatin IV 2 hour day 8 . Courses repeat every 3 week least 2 course absence disease progression unacceptable toxicity . Cohorts 3-5 patient receive escalate dos gemcitabine maximum tolerate dose ( MTD ) determine . The MTD define dose precede least 2 5 patient experience dose limit toxicity . Patients follow every 3 month 2 year , every 6 month 3 year , annually thereafter . PROJECTED ACCRUAL : A maximum 18 patient accrue study within 18 month .</detailed_description>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm metastatic recurrent nonhematologic malignancy amenable failed standard therapy Measurable evaluable disease No uncontrolled brain metastasis PATIENT CHARACTERISTICS : Age : Over 18 Performance status : ECOG 02 Life expectancy : At least 8 week Hematopoietic : Neutrophil count least 2,000/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great 1.5 mg/dL SGOT great 5 time upper limit normal Renal : Creatinine great 1.5 mg/dL Creatinine clearance least 60 mL/min Pulmonary : No respiratory failure Other : Not pregnant nursing Fertile patient must use effective contraception No active infection concurrent severe medical illness would interfere compliance PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 4 week since prior chemotherapy ( 6 week since nitrosoureas ) recover No prior cisplatin gemcitabine Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy recover No concurrent radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>